GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Global Health Clinics Ltd (XCNQ:MJRX) » Definitions » Shiller PE Ratio

Global Health Clinics (XCNQ:MJRX) Shiller PE Ratio : (As of Dec. 11, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Global Health Clinics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Global Health Clinics Shiller PE Ratio Historical Data

The historical data trend for Global Health Clinics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health Clinics Shiller PE Ratio Chart

Global Health Clinics Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Global Health Clinics Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Global Health Clinics's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Global Health Clinics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Health Clinics's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Global Health Clinics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Global Health Clinics's Shiller PE Ratio falls into.



Global Health Clinics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Global Health Clinics's E10 for the quarter that ended in Jul. 2024 is calculated as:

For example, Global Health Clinics's adjusted earnings per share data for the three months ended in Jul. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jul. 2024 (Change)*Current CPI (Jul. 2024)
=-0.03/128.0748*128.0748
=-0.030

Current CPI (Jul. 2024) = 128.0748.

Global Health Clinics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201410 -0.500 99.473 -0.644
201501 -3.926 98.209 -5.120
201504 -2.500 99.710 -3.211
201507 -0.500 100.579 -0.637
201510 -1.344 100.500 -1.713
201601 -2.082 100.184 -2.662
201604 -0.060 101.370 -0.076
201607 -0.070 101.844 -0.088
201610 -0.100 102.002 -0.126
201701 -8.000 102.318 -10.014
201704 -54.400 103.029 -67.625
201707 -230.518 103.029 -286.557
201710 -22.000 103.424 -27.244
201801 -4.000 104.056 -4.923
201804 -3.000 105.320 -3.648
201807 -10.400 106.110 -12.553
201810 -6.000 105.952 -7.253
201901 -4.000 105.557 -4.853
201904 -2.600 107.453 -3.099
201907 -56.400 108.243 -66.733
201910 -1.200 107.927 -1.424
202001 -0.800 108.085 -0.948
202004 -1.800 107.216 -2.150
202007 -1.296 108.401 -1.531
202010 -0.200 108.638 -0.236
202101 -1.000 109.192 -1.173
202104 -0.200 110.851 -0.231
202107 -2.293 112.431 -2.612
202110 -0.110 113.695 -0.124
202201 -0.130 114.801 -0.145
202204 -0.060 118.357 -0.065
202207 -0.070 120.964 -0.074
202210 -0.060 121.517 -0.063
202301 -0.030 121.596 -0.032
202304 -0.050 123.571 -0.052
202307 -0.030 124.914 -0.031
202310 -0.030 125.310 -0.031
202401 -0.030 125.072 -0.031
202404 -0.030 126.890 -0.030
202407 -0.030 128.075 -0.030

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Global Health Clinics  (XCNQ:MJRX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Global Health Clinics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Global Health Clinics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Health Clinics Business Description

Traded in Other Exchanges
Address
837 West Hastings Street, Suite 400, Vancouver, BC, CAN, V6C 3N6
Global Health Clinics Ltd engages in the cannabis industry and operates medical clinics which guide patients through the process of becoming legal users of marijuana and also engages in developing psilocybin products for research and their potential usage for pharmaceutical purposes. The Company operates in two operating segments the operating of medical clinics to guide patients to become legal users of marijuana and the development of psilocybin products for research and potential usage for pharmaceutical purposes. The Company derives its key revenue from Medical Clinics for legal user of Marijuana.

Global Health Clinics Headlines

No Headlines